ARCA gets FDA approval of IND for Covid-19 drug candidate AB201

This article was originally published here

With the IND approval in place, the company expects to launch a phase 2b/3 sequential clinical trial of AB201 in the fourth quarter of 2020. The phase 2b

The post ARCA gets FDA approval of IND for Covid-19 drug candidate AB201 appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply